To DE-obligate funds from FY2019 expiring lines in accordance with NIH oalm communication
Ended Awarded Last action
- Contract number
- 75N91019F00010
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,159
Award facts
- Contract value 100% obligated
- $10,158.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,386 | |
| Original award | $13,545 |
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Life Technologies Corporation (doing business as Thermo Fisher Scientific) with a ceiling value of $10,158.75. The award, made on October 29, 2018, is structured as a firm fixed-price engagement with an ultimate completion date of July 29, 2024. The contract was issued to de-obligate expiring fiscal year 2019 funds in accordance with NIH Office of Administration and Management Communications. No set-aside designation was applied to this procurement, reflecting Life Technologies' competitive positioning in the federal scientific equipment and services marketplace. Performance of work was conducted at the contractor's facility in Carlsbad, California.
Life Technologies Corporation, a prominent for-profit manufacturer of scientific instruments, reagents, and consumables, regularly supplies specialized biotechnology products and services to federal agencies including the NIH, Department of Defense, Centers for Disease Control and Prevention, and law enforcement entities. The company's federal contract portfolio encompasses advanced laboratory equipment such as genetic analyzers, real-time PCR systems, and DNA sequencing platforms, along with maintenance and technical support services. This NCI call order represents a continuation of the company's ongoing relationship with the National Institutes of Health in supporting critical biomedical research capabilities through its established BPA vehicle.
Quick answers
Who was awarded contract 75N91019F00010?
75N91019F00010 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on October 29, 2018.
How much is contract 75N91019F00010 worth?
The government has obligated $10,159 on 75N91019F00010.
Is contract 75N91019F00010 an order under another contract?
Yes. 75N91019F00010 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N91019F00010 competed?
The extent of competition for 75N91019F00010 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award